Clinical Trial Update: Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7) [Phase 3]

View source ↗

Summary

Phase 3 STRIDE-7 trial results report safety and immunogenicity data for the V116 pneumococcal vaccine in adults living with HIV, with results posted in July 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Pneumococcal Disease

Drugs mentioned

• V116

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pneumococcal Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-07-25